NEL ASA | Income Statement

Fiscal year is January-December. All values NOK Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
156.90
12,066.60
88,539.20
98,446.40
286,365.00
453,187
Cost of Goods Sold (COGS) incl. D&A
7,056.70
14,254.30
87,519.30
131,536.90
329,627.00
545,741
Gross Income
6,899.70
2,187.70
1,020.00
33,090.50
43,262.00
92,554
SG&A Expense
31,365.10
10,884.80
30,612.90
38,253.50
85,961.00
139,369
EBIT
38,264.90
13,072.50
29,592.90
71,344.00
129,223.00
231,923
Unusual Expense
1,194.80
100.00
51.80
-
-
-
Non Operating Income/Expense
2,314.50
727.30
13,399.20
16,316.60
16,591.00
37,408
Interest Expense
51.00
192.50
551.60
7,077.00
7,183.00
1,529
Pretax Income
36,632.60
11,633.20
14,493.80
59,705.60
117,373.00
192,772
Income Tax
-
5,121.80
6,049.00
6,808.10
72,000.00
8,676
Equity in Affiliates
-
-
13,285.90
2,931.60
7,074.00
4,731
Consolidated Net Income
36,632.60
6,511.40
21,730.70
55,829.10
52,447.00
188,827
Net Income
36,632.60
6,511.40
21,730.70
55,829.10
52,447.00
188,827
Net Income After Extraordinaries
36,632.60
6,511.40
21,730.70
55,829.10
52,447.00
188,827
Net Income Available to Common
36,632.60
6,511.40
21,730.70
55,829.10
52,447.00
188,827
EPS (Basic)
1.34
0.02
0.04
0.08
0.06
0.18
Basic Shares Outstanding
27,370.00
273,732.50
524,611.20
683,988.80
837,199.80
1,054,096.90
EPS (Diluted)
1.34
0.02
0.04
0.08
0.06
0.18
Diluted Shares Outstanding
27,370.00
273,732.50
524,611.20
683,988.80
837,199.80
1,054,096.90
EBITDA
37,533.80
9,521.40
14,080.70
60,913.20
93,255.00
167,453
Non-Operating Interest Income
563.60
1,004.60
2,303.20
2,398.80
2,442.00
3,271

About NEL ASA

View Profile
Address
Karenslyst allé 20
Oslo PS 0278
Norway
Employees -
Website http://www.nel-asa.com
Updated 07/08/2019
NEL ASA develops diagnostic tests for the early detection of diseases based on gene expression signatures in blood samples. It operates through the In vitro diagnostic (IVD) and hydrogen segments. The In vitro diagnostic segment consists of developing innovative and patient friendly IVD products for early detection of diseases.